Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents
Open Access
- 17 December 2007
- journal article
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 179 (6) , 1261-1273
Abstract
Ultraviolet B and genotoxic drugs induce the expression of a vascular endothelial growth factor A (VEGF-A) splice variant (VEGF111) encoded by exons 1–4 and 8 in many cultured cells. Although not detected in a series of normal human and mouse tissue, VEGF111 expression is induced in MCF-7 xenografts in nude mice upon treatment by camptothecin. The skipping of exons that contain proteolytic cleavage sites and extracellular matrix–binding domains makes VEGF111 diffusible and resistant to proteolysis. Recombinant VEGF111 activates VEGF receptor 2 (VEGF-R2) and extracellularly regulated kinase 1/2 in human umbilical vascular endothelial cells and porcine aortic endothelial cells expressing VEGF-R2. The mitogenic and chemotactic activity and VEGF111's ability to promote vascular network formation during embyonic stem cell differentiation are similar to those of VEGF121 and 165. Tumors in nude mice formed by HEK293 cells expressing VEGF111 develop a more widespread network of numerous small vessels in the peritumoral tissue than those expressing other isoforms. Its potent angiogenic activity and remarkable resistance to proteolysis makes VEGF111 a potential adverse factor during chemotherapy but a beneficial therapeutic tool for ischemic diseases.Keywords
This publication has 41 references indexed in Scilit:
- Smoking-Induced Monocyte Dysfunction Is Reversed by Vitamin C Supplementation In VivoArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formationBlood, 2006
- Domains and Maturation Processes That Regulate the Activity of ADAMTS-2, a Metalloproteinase Cleaving the Aminopropeptide of Fibrillar Procollagens Types I–III and VJournal of Biological Chemistry, 2005
- RGDS and DGEA-induced [Ca2+]i signalling in human dermal fibroblastsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2005
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- The Carboxyl-terminal Domain(111–165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic PotencyJournal of Biological Chemistry, 1996
- Structural requirements for dimerization, glycosylation, secretion, and biological function of VPF/VEGFBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1995
- Formation of 8-Hydroxy-2′-deoxyguanosine in Epidermis of Hairless Mice Exposed to Near-UVBiochemical and Biophysical Research Communications, 1994
- Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing.Journal of Experimental Medicine, 1992
- Glycosylation of vascular endothelial growth factor is not required for its mitogenic activityBiochemical and Biophysical Research Communications, 1992